|
|
Article: NOT HUMAN EMBRYONIC BUT ADULT ANIMAL CELLS DIABETIC, MACULAR RETINOPATHIES TREATABLE BY STEM CELL INJECTIONS TO EYES OF OCULAR MOUSE MODELS.
- Article from:
- BIOWORLD Today
- Article date:
- August 5, 2002
- Author:
CopyrightCOPYRIGHT 2002 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"Diabetic retinopathy is the leading cause of vision loss in working- age Americans," observed clinical ophthalmologist and cell/molecular biologist Martin Friedlander at the Scripps Research Institute in La Jolla, Calif. "The prevalence of diabetes is 16 percent to 17 percent of the U.S. population," he pointed out.
"Of those diabetics under 55, virtually every one of them will have some kind of a diabetic retinopathy, after 20 years of the disease. Their current rate of some vision loss from the disease counts about 40,000 Americans per year. And 12 million to 15 million Americans over the age of 65," Friedlander added, "will acquire macular degeneration, ...